NCT01103024View on ClinicalTrials.gov

Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious Uveitis

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2010

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions
Uveitis
Interventions
BIOLOGICAL

AIN457

BIOLOGICAL

AIN457

BIOLOGICAL

AIN457

BIOLOGICAL

Placebo

Trial Locations (11)

52621

Novartis Investigative Site, Ramat Gan

76012

Texas Retina Associates, Arlington

Unknown

Novartis Investigative Site, London

Novartis Investigative Site, North York

Novartis Investigative Site, Bunkyō City

Novartis Investigative Site, Fukuoka

Novartis Investigative Site, Fukushima

Novartis Investigative Site, Sapporo

Novartis Investigative Site, Tochigi

Novartis Investigative Site, Bern

602-0841

Novartis Investigational Site, Kyoto

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY